Micah Kee

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Systematic Review

Decision Making

Top Venues

Clinical drug investigation

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Katherine Cox, Merhawit Ghebrehiwet, Micah Kee, Brayden M Rucker, Holly Flores, Ryan Ottwell, Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin. Clinical drug investigation (2023)
Katherine Cox, Merhawit Ghebrehiwet, Micah Kee, Brayden M Rucker, Holly Flores, Ryan Ottwell, Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin. Clinical drug investigation 43 (2) (2023)
Katherine Cox, Merhawit Ghebrehiwet, Micah Kee, Brayden M Rucker, Holly Flores, Ryan Ottwell, Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin. Clinical drug investigation 43 (2) (2023)
Katherine Cox, Merhawit Ghebrehiwet, Micah Kee, Brayden M Rucker, Holly Flores, Ryan Ottwell, Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin. Clinical drug investigation 43 (2) (2023)
Katherine Cox, Merhawit Ghebrehiwet, Micah Kee, Brayden M Rucker, Holly Flores, Ryan Ottwell, Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin. Clinical drug investigation 43 (2) (2023)
Reece M Anderson, Sam Streck, Griffin K Hughes, Bethany Sutterfield, Micah Kee, Audrey Wise, Cody Hillman, Ryan Ottwell, Micah L Hartwell, Matt Vassar
Evaluating reporting of patient-reported outcomes in peptic ulcer disease: a meta-epidemiological study of randomized controlled trials. Expert review of pharmacoeconomics & outcomes research 22 (8) (2022)